Tuesday was a rough day on the market, with the All Ordinaries Index (ASX: XAO) closing 0.99% lower.
That's better than its intraday performance. At its lowest point of the day, the index was sporting a 2.5% tumble.
But two All Ords shares stood out among the pack, managing to dodge most of the carnage to record new 52- week highs? Let's take a look.
2 ASX All Ordinaries shares hitting new 52-week highs
Amcor Plc (ASX: AMC)
The Amcor share price hit an all-time high of $18.26 on Tuesday despite the All Ordinaries' woes. Interestingly, the company met its new record without releasing any news to the market.
Amcor produces packaging solutions for products like food, beverages, and pharmaceuticals. It operates in more than 40 countries and is listed on both the ASX and the New York Stock Exchange.
The last time the market heard from the company was last week when it released its results for the quarter ended 31 March.
Over the period, Amcor brought in US$3.7 billion of sales – a US$500 million increase on those of the prior comparable quarter.
That likely helped it make a gross profit of US$731 million – a 7% increase.
The Amcor share price has gained 10% since the start of 2022, outperforming the All Ordinaries Index by nearly 18% year to date.
Regis Healthcare Ltd (ASX: REG)
The Regis Healthcare share price leapt 2.5% to a new 52-week high of $2.34 before tumbling to join the All Ordinaries Index in the red today.
The residential care home operator hasn't released any news to the ASX this month. Still, the market has been bidding its share price higher. It's gained 5% since the end of April.
The last time the ASX heard from Regis Healthcare was on 14 April. Then, the company announced it had settled a legal dispute brought against its subsidiary, Regis Aged Care by Oneview Healthcare (ASX: ONE).
Oneview Healthcare previously alleged Regis Healthcare breached a collaboration agreement.
The case was settled without either party admitting liability.
The Regis Healthcare share price has gained nearly 19% since the start of 2022. By doing so, it has beaten the All Ordinaries Index's 2022 performance by 25%.
